Caplan Jay David
President, Chief Product Off. at GUTS
- Sold, on record
- $429k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jan 31, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- GUTSFRACTYL HEALTH, INC.President, Chief Product Off.
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice GUTSNoticeSep 12, 2024 2024
Filed to sell 65,000 shares ($185k)
Caplan Jay David, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale GUTSUnusualSep 12, 2024 same day
Sold 65,000 shares at $2.90 ($189k)
Caplan Jay David, President, Chief Product Off.
No 10b5-1 planSold 68.1% of holdings ($277k position)30,484 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale GUTSUnusualNov 11, 2024 +60 days
Sold 64,197 shares at $2.47 ($159k)
Caplan Jay David, President, Chief Product Off.
No 10b5-1 planSold 29.5% of holdings ($538k position)153,544 shares leftFiling
- 4 Form 144 notice GUTSNoticeJan 30, 2025 +80 days
Filed to sell 43,818 shares ($89k)
Caplan Jay David, Officer
10b5-1 planFiling
- 5 Form 4 sale GUTSRoutineJan 31, 2025 +1 day
Sold 43,818 shares at $1.88 ($82k)
Caplan Jay David, President, Chief Product Off.
10b5-1 planSold 22.2% of holdings ($371k position)153,544 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Feb 3, 2025 | GUTS | President, Chief Product Off. | Form 4 sale | 43,818 | $82k | 22.2% | Routine | SEC |
| Jan 30, 2025 | Jan 30, 2025 | GUTS | Officer | Form 144 notice | 43,818 | $89k | Notice | SEC | |
| Nov 11, 2024 | Nov 13, 2024 | GUTS | President, Chief Product Off. | Form 4 sale | 64,197 | $159k | 29.5% | Unusual | SEC |
| Sep 12, 2024 | Sep 13, 2024 | GUTS | President, Chief Product Off. | Form 4 sale | 65,000 | $189k | 68.1% | Unusual | SEC |
| Sep 12, 2024 | Sep 12, 2024 | GUTS | Officer | Form 144 notice | 65,000 | $185k | Notice | SEC |